The launch of BrightMeds GLP-1 signifies a crucial shift in how physicians handle diabetes mellitus . This advanced medication category delivers a unique mechanism of action that also lowers blood glucose levels but may encourage a reduction in weight and boost heart outcomes. Early results sugge